Article Text

Download PDFPDF
The fibrillin-1 gene: unlocking new therapeutic pathways in cardiovascular disease

Footnotes

  • Funding Dr Barrett has received an unrestricted research grant from A Menarini Pharmaceuticals Inc. and Daiichi Sankyo Inc.

  • Competing interests None.

  • Provenance and peer review Commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Funding Dr Barrett has received an unrestricted research grant from A Menarini Pharmaceuticals Inc. and Daiichi Sankyo Inc.

  • Competing interests None.

  • Provenance and peer review Commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.